These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32115649)

  • 1. Perioperative therapies for urological cancers.
    Inokuchi J; Yokomizo A; Nishiyama N; Kitamura H; Eto M; Nishiyama H; Tomita Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):357-367. PubMed ID: 32115649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
    Schmid SC; Koll FJ; Beckert F; Seitz AK
    Urologe A; 2020 Jul; 59(7):790-796. PubMed ID: 32472221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis.
    Gregg RW; Vera-Badillo FE; Booth CM; Mahmud A; Brundage M; Leveridge MJ; Hanna TP
    Crit Rev Oncol Hematol; 2018 Aug; 128():58-64. PubMed ID: 29958631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies.
    Massari F; Santoni M; di Nunno V; Cheng L; Lopez-Beltran A; Cimadamore A; Gasparrini S; Scarpelli M; Battelli N; Montironi R
    Cancer Treat Rev; 2018 Jul; 68():80-85. PubMed ID: 29886353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on perioperative systemic therapy for urothelial carcinoma.
    Rouvinov K; Plimack ER; Zibelman M; Ghatalia P; Geynisman DM
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):176-183. PubMed ID: 30969956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chemotherapy in upper urinary tract urothelial cell cancers.
    Kwan A; Mazhar D
    Future Oncol; 2011 Sep; 7(9):1067-75. PubMed ID: 21919694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
    Audenet F; Yates DR; Cussenot O; Rouprêt M
    Urol Oncol; 2013 May; 31(4):407-13. PubMed ID: 20884249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.
    Birtle AJ; Lewis R; Johnson M; Hall E;
    BJU Int; 2012 Oct; 110(7):919-21. PubMed ID: 22882350
    [No Abstract]   [Full Text] [Related]  

  • 10. Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
    Koie T; Ohyama C; Fujimoto H; Nishiyama H; Miyazaki J; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T; ; Ohyama C; Nishiyama H; Fujisawa M; Uemura H; Fujimoto H; Suzuki K; Eto M; Hara I; Matsubara A; Nonomura N; Nakanishi H; Koie T; Kanayama H; Miki T; Fukumori T; Naito S;
    Jpn J Clin Oncol; 2016 May; 46(5):468-74. PubMed ID: 26851754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant systemic therapy for urological malignancies.
    Sonpavde G; Sternberg CN
    BJU Int; 2010 Jul; 106(1):6-22. PubMed ID: 20553475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of methotrexate, vinblastine, doxorubicin and cisplatin adjuvant chemotherapy following radical surgery for locally invasive urothelial cancers: long-term results].
    Tachibana M; Miyakawa A; Nakashima J; Nakamura K; Deguchi N; Baba S; Murai M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1016-21. PubMed ID: 7596077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
    Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
    Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
    Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection of urological tumor metastases following medical treatment.
    Heidenreich A; Wilop S; Pinkawa M; Porres D; Pfister D
    Dtsch Arztebl Int; 2012 Sep; 109(39):631-7. PubMed ID: 23093995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence-based medicine for urological cancer chemotherapy].
    Tsukamoto S; Miyanaga N; Kawai K; Akaza H
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):183-91. PubMed ID: 10700888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.
    Xylinas E; Rink M; Margulis V; Karakiewicz PI; Bensalah K; Shariat SF;
    Eur Urol; 2012 Jul; 62(1):e25-6. PubMed ID: 22537797
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.
    Miyake M; Owari T; Iwamoto T; Morizawa Y; Hori S; Marugami N; Shimada K; Iida K; Ohnishi K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Yoneda T; Tanaka N; Fujimoto K
    Support Care Cancer; 2018 Apr; 26(4):1077-1086. PubMed ID: 29022158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.